» Articles » PMID: 20711435

Update on the Management of Constipation in the Elderly: New Treatment Options

Overview
Publisher Dove Medical Press
Specialty Geriatrics
Date 2010 Aug 17
PMID 20711435
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Constipation disproportionately affects older adults, with a prevalences of 50% in community-dwelling elderly and 74% in nursing-home residents. Loss of mobility, medications, underlying diseases, impaired anorectal sensation, and ignoring calls to defecate are as important as dyssynergic defecation or irritable bowel syndrome in causing constipation. Detailed medical history on medications and co-morbid problems, and meticulous digital rectal examination may help identify causes of constipation. Likewise, blood tests and colonoscopy may identify organic causes such as colon cancer. Physiological tests such as colonic transit study with radio-opaque markers or wireless motility capsule, anorectal manometry, and balloon expulsion tests can identify disorders of colonic and anorectal function. However, in the elderly, there is usually more than one mechanism, requiring an individualized but multifactorial treatment approach. The management of constipation continues to evolve. Although osmotic laxatives such as polyethylene glycol remain mainstay, several new agents that target different mechanisms appear promising such as chloride-channel activator (lubiprostone), guanylate cyclase agonist (linaclotide), 5HT(4) agonist (prucalopride), and peripherally acting mu-opioid receptor antagonists (alvimopan and methylnaltrexone) for opioid-induced constipation. Biofeedback therapy is efficacious for treating dyssynergic defecation and fecal impaction with soiling. However, data on efficacy and safety of drugs in elderly are limited and urgently needed.

Citing Articles

LRJ-1 alleviates constipation through promoting gut -derived γ-aminobutyric acid production.

Xia T, Huang F, Yun F, Liu Y, Wang T, Wang S Curr Res Food Sci. 2024; 9:100924.

PMID: 39619641 PMC: 11605182. DOI: 10.1016/j.crfs.2024.100924.


Effect of KiwiBiotic on functional constipation and related symptoms: A prospective, single-center, randomized, comparative, crossover study.

Porwal A, Gandhi P, Kulkarni D, Bhagwat G, Kamble P World J Gastrointest Pharmacol Ther. 2024; 15(5):97330.

PMID: 39281263 PMC: 11401019. DOI: 10.4292/wjgpt.v15.i5.97330.


A survey on functional constipation and its risk factors in older people in Shahreza, Iran.

Amiri M, Hassanzadeh A, Rahimi M J Educ Health Promot. 2024; 13:118.

PMID: 38726080 PMC: 11081462. DOI: 10.4103/jehp.jehp_345_23.


Development and validation of a nomogram to predict the risk of constipation after lumbar interbody fusion surgery.

Chen M, Cheng S, Zhong D, Hu T, Wang X, Deng Z Arch Orthop Trauma Surg. 2024; 144(5):1907-1916.

PMID: 38483619 DOI: 10.1007/s00402-024-05256-y.


Chronic Liver Disease in the Older Patient-Evaluation and Management.

DiLeo D, Gidener T, Aytaman A Curr Gastroenterol Rep. 2023; 25(12):390-400.

PMID: 37991713 DOI: 10.1007/s11894-023-00908-2.


References
1.
Rao S, Go J . Treating pelvic floor disorders of defecation: management or cure?. Curr Gastroenterol Rep. 2009; 11(4):278-87. PMC: 3883497. DOI: 10.1007/s11894-009-0041-3. View

2.
Rao S . Constipation: evaluation and treatment of colonic and anorectal motility disorders. Gastroenterol Clin North Am. 2007; 36(3):687-711, x. DOI: 10.1016/j.gtc.2007.07.013. View

3.
Herz M, Kahan E, Zalevski S, Aframian R, Kuznitz D, REICHMAN S . Constipation: a different entity for patients and doctors. Fam Pract. 1996; 13(2):156-9. DOI: 10.1093/fampra/13.2.156. View

4.
Lembo A, Kurtz C, MacDougall J, Lavins B, Currie M, Fitch D . Efficacy of linaclotide for patients with chronic constipation. Gastroenterology. 2010; 138(3):886-95.e1. DOI: 10.1053/j.gastro.2009.12.050. View

5.
Nyam D, Pemberton J, Ilstrup D, Rath D . Long-term results of surgery for chronic constipation. Dis Colon Rectum. 1997; 40(3):273-9. DOI: 10.1007/BF02050415. View